BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18158318)

  • 21. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
    Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
    Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
    Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOCS3 regulates the plasticity of gp130 signaling.
    Lang R; Pauleau AL; Parganas E; Takahashi Y; Mages J; Ihle JN; Rutschman R; Murray PJ
    Nat Immunol; 2003 Jun; 4(6):546-50. PubMed ID: 12754506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection.
    Bard-Chapeau EA; Yuan J; Droin N; Long S; Zhang EE; Nguyen TV; Feng GS
    Mol Cell Biol; 2006 Jun; 26(12):4664-74. PubMed ID: 16738330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.
    Cho-Vega JH; Rassidakis GZ; Amin HM; Tsioli P; Spurgers K; Remache YK; Vega F; Goy AH; Gilles F; Medeiros LJ
    Leukemia; 2004 Nov; 18(11):1872-8. PubMed ID: 15385932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
    Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
    Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27.
    Brender C; Tannahill GM; Jenkins BJ; Fletcher J; Columbus R; Saris CJ; Ernst M; Nicola NA; Hilton DJ; Alexander WS; Starr R
    Blood; 2007 Oct; 110(7):2528-36. PubMed ID: 17609432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo.
    Yang XP; Schaper F; Teubner A; Lammert F; Heinrich PC; Matern S; Siewert E
    J Hepatol; 2005 Oct; 43(4):704-10. PubMed ID: 16040151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis.
    Moreno-Carranza B; Goya-Arce M; Vega C; Adán N; Triebel J; López-Barrera F; Quintanar-Stéphano A; Binart N; Martínez de la Escalera G; Clapp C
    Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R720-6. PubMed ID: 23948778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dual function of hepatic SOCS3 in insulin resistance in vivo.
    Torisu T; Sato N; Yoshiga D; Kobayashi T; Yoshioka T; Mori H; Iida M; Yoshimura A
    Genes Cells; 2007 Feb; 12(2):143-54. PubMed ID: 17295835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme.
    Zhou H; Miki R; Eeva M; Fike FM; Seligson D; Yang L; Yoshimura A; Teitell MA; Jamieson CA; Cacalano NA
    Clin Cancer Res; 2007 Apr; 13(8):2344-53. PubMed ID: 17438093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration.
    Nagai H; Tokumaru S; Sayama K; Shirakata Y; Hanakawa Y; Hirakawa S; Dai X; Tohyama M; Yang L; Hashimoto K
    J Dermatol; 2007 Aug; 34(8):523-30. PubMed ID: 17683382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
    Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
    Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermal injury-induced increases of hepatocyte SOCS3 lead to decreases in STAT3.
    Kong F; Guo X; Noel JG; Wells DA; Lovell GJ; Ogle CK
    Shock; 2002 Oct; 18(4):374-9. PubMed ID: 12392283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth control by SOCS1 and SOCS3.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Kandhi R; Ramanathan S; Ilangumaran S
    Cytokine; 2019 Sep; 121():154733. PubMed ID: 31154249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of SOCS3 suppresses human lung adenocarcinoma cell growth by downregulating activation of Erk1/2, Akt apart from STAT3.
    Yu ZB; Bai L; Qian P; Xiao YB; Wang GS; Qian GS; Bai CX; Min JX
    Cell Biol Int; 2009 Sep; 33(9):995-1001. PubMed ID: 19524687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.
    Haga S; Ozaki M; Inoue H; Okamoto Y; Ogawa W; Takeda K; Akira S; Todo S
    Hepatology; 2009 Jan; 49(1):204-14. PubMed ID: 19065678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.